Natixis Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.57M | Buy |
36,392
+3,080
| +9% | +$387K | 0.01% | 840 |
|
|
2025
Q1 | $3.68M | Sell |
33,312
-292
| -0.9% | -$32.3K | 0.01% | 887 |
|
|
2024
Q4 | $4.59M | Buy |
33,604
+4,277
| +15% | +$584K | 0.01% | 843 |
|
|
2024
Q3 | $3.38M | Sell |
29,327
-5,933
| -17% | -$684K | 0.01% | 932 |
|
|
2024
Q2 | $4.85M | Buy |
35,260
+3,531
| +11% | +$486K | 0.01% | 804 |
|
|
2024
Q1 | $4.38M | Buy |
31,729
+1,898
| +6% | +$262K | 0.01% | 834 |
|
|
2023
Q4 | $3.93M | Sell |
29,831
-512
| -2% | -$67.5K | 0.01% | 821 |
|
|
2023
Q3 | $3.41M | Buy |
30,343
+5,573
| +22% | +$627K | 0.01% | 824 |
|
|
2023
Q2 | $2.34M | Sell |
24,770
-29,481
| -54% | -$2.78M | 0.01% | 914 |
|
|
2023
Q1 | $5.49M | Sell |
54,251
-6,941
| -11% | -$703K | 0.02% | 665 |
|
|
2022
Q4 | $7.31M | Sell |
61,192
-9,270
| -13% | -$1.11M | 0.03% | 563 |
|
|
2022
Q3 | $7.48M | Buy |
70,462
+3,667
| +5% | +$389K | 0.03% | 509 |
|
|
2022
Q2 | $6.51M | Buy |
66,795
+6,446
| +11% | +$628K | 0.03% | 575 |
|
|
2022
Q1 | $5.66M | Buy |
60,349
+32,746
| +119% | +$3.07M | 0.02% | 642 |
|
|
2021
Q4 | $2.35M | Sell |
27,603
-13,419
| -33% | -$1.14M | 0.01% | 902 |
|
|
2021
Q3 | $3.93M | Buy |
41,022
+5,890
| +17% | +$565K | 0.02% | 717 |
|
|
2021
Q2 | $3.42M | Buy |
35,132
+1,094
| +3% | +$106K | 0.02% | 747 |
|
|
2021
Q1 | $3.31M | Buy |
34,038
+3,654
| +12% | +$355K | 0.02% | 732 |
|
|
2020
Q4 | $2.91M | Sell |
30,384
-3,632
| -11% | -$348K | 0.02% | 735 |
|
|
2020
Q3 | $3.27M | Buy |
34,016
+19,003
| +127% | +$1.83M | 0.02% | 655 |
|
|
2020
Q2 | $1.83M | Buy |
15,013
+446
| +3% | +$54.4K | 0.01% | 830 |
|
|
2020
Q1 | $1.26M | Buy |
14,567
+2,814
| +24% | +$244K | 0.01% | 845 |
|
|
2019
Q4 | $1.26M | Buy |
11,753
+1,135
| +11% | +$122K | 0.01% | 933 |
|
|
2019
Q3 | $957K | Buy |
+10,618
| New | +$957K | 0.01% | 941 |
|